Chronic kidney disease, most commonly caused by diabetes and high blood pressure, puts more than half a billion people globally at high risk for kidney failure, cardiovascular events, and death. Treatment with semaglutide may significantly reduce this risk, according to a randomized study involving 3533 patients with type 2 diabetes and chronic kidney disease.
